Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise

[1]  H. Holmberg,et al.  Heterogeneity in subcellular muscle glycogen utilisation during exercise impacts endurance capacity in men , 2020, The Journal of physiology.

[2]  M. Gillum,et al.  Differential time responses in inflammatory and oxidative stress markers after a marathon: An observational study , 2020, Journal of sports sciences.

[3]  C. Franceschi,et al.  GDF15 Plasma Level Is Inversely Associated With Level of Physical Activity and Correlates With Markers of Inflammation and Muscle Weakness , 2020, Frontiers in Immunology.

[4]  D. O'Gorman,et al.  Growth and Differentiation Factor 15 is secreted by skeletal muscle during exercise and promotes lipolysis in humans. , 2020, JCI insight.

[5]  H. Grill,et al.  GDF15 Induces Anorexia through Nausea and Emesis. , 2020, Cell metabolism.

[6]  S. O’Rahilly,et al.  GDF15 mediates the effects of metformin on body weight and energy balance , 2019, Nature.

[7]  S. Klaus,et al.  Role of GDF15 in active lifestyle induced metabolic adaptations and acute exercise response in mice , 2019, Scientific Reports.

[8]  Amogelang R. Raphenya,et al.  Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss , 2019, Nature Metabolism.

[9]  M. Pisani,et al.  GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance , 2019, Cell.

[10]  G. Bray,et al.  GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans , 2019, Cell Metabolism.

[11]  R. Seeley,et al.  GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice , 2019, Molecular metabolism.

[12]  R. Z. Pinto,et al.  Interleukin‐10 responses from acute exercise in healthy subjects: A systematic review , 2018, Journal of cellular physiology.

[13]  R. Fisichella,et al.  Comment on "Research on values of GDF-15 level in the diagnosis of primary liver cancer and evaluation of chemotherapeutic effect". , 2018, European review for medical and pharmacological sciences.

[14]  A. Sainsbury,et al.  The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases. , 2018, Cell metabolism.

[15]  M. Gillum,et al.  Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans. , 2018, JCI insight.

[16]  Shannon E. Mullican,et al.  Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond , 2018, Trends in Endocrinology & Metabolism.

[17]  J. Holst,et al.  Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control. , 2018, Cell metabolism.

[18]  J. Wojtaszewski,et al.  Exercise increases circulating GDF15 in humans , 2018, Molecular metabolism.

[19]  Y. Shen,et al.  Research on values of GDF-15 level in the diagnosis of primary liver cancer and evaluation of chemotherapeutic effect. , 2018, European review for medical and pharmacological sciences.

[20]  Hantao Liu,et al.  Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys , 2017, Science Translational Medicine.

[21]  Jie Tang,et al.  Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15 , 2017, Nature.

[22]  Søren B. Padkjær,et al.  GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand , 2017, Nature Medicine.

[23]  P. Emmerson,et al.  The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL , 2017, Nature Medicine.

[24]  T. Cash-Mason,et al.  GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates , 2017, Nature Medicine.

[25]  T. Lyberg,et al.  Plasma Cytokine Profiles in Long-Term Strenuous Exercise , 2016, Journal of sports medicine.

[26]  S. Shinkai,et al.  Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age‐related disorders , 2016, Geriatrics & gerontology international.

[27]  A. Astrup,et al.  Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI , 2015, PloS one.

[28]  G. Banfi,et al.  Acute exercise in elite rugby players increases the circulating level of the cardiovascular biomarker GDF-15 , 2014, Scandinavian journal of clinical and laboratory investigation.

[29]  K. Sahlin,et al.  Muscle glycogen content modifies SR Ca2+ release rate in elite endurance athletes. , 2014, Medicine and science in sports and exercise.

[30]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[31]  I. Papassotiriou,et al.  Growth-differentiation factor-15, endoglin and N-terminal pro-brain natriuretic peptide induction in athletes participating in an ultramarathon foot race , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[32]  James A King,et al.  Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[33]  A. Steensberg,et al.  Exercise and interleukin-6 , 2001, Current opinion in hematology.

[34]  W. D. Fairlie,et al.  MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Tremblay,et al.  Acute effects of exercise on energy intake and feeding behaviour , 1997, British Journal of Nutrition.

[36]  E Hultman,et al.  Diet, muscle glycogen and physical performance. , 1967, Acta physiologica Scandinavica.